Drotaverine hydrochloride
CAS No. 985-12-6
Drotaverine hydrochloride ( —— )
产品货号. M22762 CAS No. 985-12-6
Drotaverine hydrochloride is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor,and is an antispasmodic drug, used to enhance cervical dilation during childbirth.?
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
|
10MG | ¥583 | 有现货 |
|
25MG | ¥1126 | 有现货 |
|
50MG | ¥2130 | 有现货 |
|
100MG | ¥3183 | 有现货 |
|
500MG | ¥7606 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Drotaverine hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Drotaverine hydrochloride is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor,and is an antispasmodic drug, used to enhance cervical dilation during childbirth.?
-
产品描述Drotaverine hydrochloride is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor,and is an antispasmodic drug, used to enhance cervical dilation during childbirth.?Drotaverine hydrochloride?is structurally related to papaverine?drotaverine not only relaxed the precontracted tracheal preparations but also decreased mediator-induced contraction.?These effects of drotaverine were concentration dependent, with a significantly higher potency on the KCl-induced response, than on either the histamine or methacholine induced one.?A similar result was noted for nifedipine.?The PDE inhibitor, theophylline, also relaxed the precontracted preparations but was ineffective on the mediator-induced contraction in a physiologically relevant concentration range.
-
同义词——
-
通路Angiogenesis
-
靶点PDE
-
受体PDE4
-
研究领域——
-
适应症——
化学信息
-
CAS Number985-12-6
-
分子量433.97
-
分子式C24H32ClNO4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.CCOc1ccc(cc1OCC)CC2=NCCc3cc(OCC)c(OCC)cc23
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Ensifentrine
Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
-
ICI 63197
ICI 63197 is a PDE4 inhibitor.
-
AMG-579
AMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.